Therefore, while RESF1 may function as a minor histocompatibility antigen in tumor-graft rejection, it does not appear to play a significant role in metastatic progression, at least in the cell line-based orthotopic transplant spontaneous metastasis models. Here, RESF1 is linked to neoplasm.